07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
Risk Management Question - How can you train your law firm employees to spot bogus charity and disa...
Read More >
“Fair value” means the value of the shares on a sale between a willing buyer and a willing seller,...
Read More >
The U.S. Department of Justice Antitrust Division (DOJ) has prevailed in a first-of-its-kind arbitra...
Read More >
For almost as long as EU merger control has existed, scholars and practitioners have discussed and d...
Read More >
Even with Pennsylvania Gov. Tom Wolf announcing today that construction projects can resume May 8, t...
Read More >
The SECURE Act* makes significant changes to employer-sponsored retirement plans and many of the cha...
Read More >